ArticleCancers2024

Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer.

Antonio Pizuorno Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.